Clinical Trials Browser

Phase 2 × Glioblastoma × Receptor Protein-Tyrosine Kinases × Clear all

NCT01753713 2017-12-12

Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma

Phase 2 Completed

33 enrolled 14 charts

Brain Neoplasms, Glioblastoma, Gliosarcoma